You are here
News
CHU de Québec Collaborates with PerkinElmer on a study funded by Genome Canada, Génome Québec, CIHR and Genome Alberta using DNA sequencing alone or in a contingent model with first trimester serum markers as non-invasive option to determine risk of Down
Monday, November 4, 2013
A team of clinical researchers led by CHU de Québec has received CAN$10.5 million from Génome Québec, Genome Canada, CIHR, Genome Alberta and other partners to recruit 5,600 pregnant women in Canada to study the potential of using DNA sequencing alone or in a contingent model with first trimester serum markers as a non-invasive method for detecting birth defects.
Call for proposals for the biobank of the Canadian Health Measures Survey
Friday, November 1, 2013
From November 1 to December 31, 2013, Statistics Canada is inviting researchers to apply for access to blood, urine and DNA samples from the Canadian Health Measures Survey (CHMS) for use in health studies. The biospecimens are available to any Canadian researcher that completes a review process and would benefit from a national population survey of about 5,600 participants per collection cycle.
Genome Canada welcomes five new Board members
Wednesday, October 30, 2013
Genome Canada is delighted to highlight the recent appointment of five new members to its Board of Directors. They include:
Fiona Brinkman, Professor, Molecular Biology and Biochemistry at Simon Fraser University
Jay Ingram, Broadcaster and Science Writer
Kim McConnell, Founder and former CEO, AdFarm
Moura Quayle, Professor, Strategic Design, Sauder School of Business, University of British Columbia
Donald Ziraldo, Co-founder, Inniskillin Wines
The Structural Genomics Consortium Announces that Janssen has joined its Public-Private Drug Discovery Partnership
Friday, October 25, 2013
The Structural Genomics Consortium (SGC) announced today that Janssen Pharmaceuticals NV has joined its group to partner in the investigation of epigenetics-based drug research, a new and burgeoning field in the development of future medicines.
Genome Canada congratulates Abdallah Daar on appointment to new UN Scientific Advisory Board
Monday, October 21, 2013
Dr. Abdallah Daar, Professor of Public Health at the University of Toronto and a Genome Canada Board member since 2012, has been appointed to a new Scientific Advisory Board of the United Nations. Dr. Daar is one of twenty-six eminent scientists appointed to the Board, representing natural, social and human sciences and engineering.
Dawn of a new era for children: Introducing Canada’s first integrated clinical genomic centre in pediatrics
Monday, October 21, 2013
Dr. Fabrice Brunet, Chief Executive Officer at Sainte-Justine UHC, and Marc LePage, President and CEO of Génome Québec, are extremely proud to announce the launch of Canada’s first integrated clinical genomic centre in pediatrics, an initiative currently at the forefront of global efforts in this area. "We are honoured to have the opportunity to make this partnership a reality in the presence of the Québec Premier, Pauline Marois, and Dr.